Article
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct-acting antivirals.
European journal of immunology - 1 Nov 2023
Bi Wenjie, Kraft Anke, Engelskircher Sophie, Mischke Jasmin, Witte Moana, Klawonn Frank, van Ham Marco, Cornberg Markus, Wedemeyer Heiner, Hengst Julia, Jänsch Lothar
Abstract excerpt
Chronic hepatitis C virus (HCV) infections compromise natural killer (NK)-cell immunity. Direct-acting antivirals (DAA) effectively eliminate HCV, but the long-term effects on NK cells in cured patients are debated. We conducted a proteomic study on CD56+ NK cells of chronic HCV-infected patients before and 1 year after DAA therapy. Donor-variation was observed in NK-cell proteomes of HCV-infected patients, with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
